What is the 13F Pro Quality Score for SVRA?

13F Pro ranks Savara Inc (SVRA) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View SVRA's current score at https://13fpro.ai/research/SVRA (free sign-up required for the full ranking).

Where does 13F Pro source SVRA data?

All Savara Inc fundamentals and ownership data come directly from SEC EDGAR. Savara Inc files with the SEC under CIK 1160308. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is SVRA in?

Savara Inc (SVRA) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is SVRA research updated on 13F Pro?

SVRA's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Savara Inc(SVRA)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1160308 SVRA stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

SVRA Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Savara Inc (SVRA), a Healthcare sector company. SVRA is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q1 2026), Savara Inc reports net income of $-37.3M, free cash flow of $-33.1M. Top institutional holders of SVRA by reported 13-F value include NEA Management Company,, Bain Capital Life Sciences Investors,, VR Adviser,, based on the most recent SEC filings. SVRA trades on the Nasdaq exchange and files with the SEC under CIK 1160308. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SVRA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Savara Inc directly from SEC EDGAR.

Net Income

Q1 2026

$-37.3M

Free Cash Flow

Q1 2026

$-33.1M

D/E Ratio

Q1 2026

0.17

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

—FY 2025

FY22 —FY23 —FY24 —FY25 —

Net Income

-23.9% YoY

$-118.8MFY 2025

FY22 $-38.1MFY23 $-54.7MFY24 $-95.9MFY25 $-118.8M

Operating Income

-19.7% YoY

$-123.5MFY 2025

FY22 $-38.8MFY23 $-60.0MFY24 $-103.2MFY25 $-123.5M

EPS (Diluted)

-10.4% YoY

$-0.53FY 2025

FY22 $-0.25FY23 $-0.33FY24 $-0.48FY25 $-0.53

Total Assets

+19.1% YoY

$253.4MFY 2025

FY22 $139.8MFY23 $177.6MFY24 $212.9MFY25 $253.4M

Total Debt

+12.4% YoY

$29.9MFY 2025

FY22 $26.1MFY23 $26.3MFY24 $26.6MFY25 $29.9M

Op. Cash Flow

-13.4% YoY

$-101.0MFY 2025

FY22 $-34.6MFY23 $-51.1MFY24 $-89.1MFY25 $-101.0M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	—	—	—	—	—	$257.0K
Net Income	$-118.8M -23.9%	$-95.9M -75.3%	$-54.7M -43.4%	$-38.1M +11.3%	$-43.0M +13.3%	$-49.6M
Operating Income	$-123.5M -19.7%	$-103.2M -72.0%	$-60.0M -54.5%	$-38.8M +6.4%	$-41.5M +15.9%	$-49.3M
EPS (Diluted)	$-0.53 -10.4%	$-0.48 -45.5%	$-0.33 -32.0%	$-0.25 +21.9%	$-0.32	—
Total Assets	$253.4M +19.1%	$212.9M +19.9%	$177.6M +27.0%	$139.8M -20.9%	$176.6M +80.7%	$97.7M
Total Debt	$29.9M +12.4%	$26.6M +1.0%	$26.3M +1.0%	$26.1M -23.3%	$34.0M +35.4%	$25.1M
Operating Cash Flow	$-101.0M -13.4%	$-89.1M -74.5%	$-51.1M -47.8%	$-34.6M +13.8%	$-40.1M -0.6%	$-39.8M

AI Insight: SVRA Ratio Trends

Savara remains deeply unprofitable with deteriorating returns; Q3 2025 marked a nadir in ROE, ROA, and ROIC before modest recovery in Q4 2025 and Q1 2026.

• ROE collapsed to -125.3% in Q3 2025, worst quarterly performance on record, before recovering to -84.7% in Q1 2026.

• ROIC declined from -46.7% in Q3 2024 to -97.5% in Q3 2025, signaling severe value destruction before modest Q4–Q1 improvement.

• Debt-to-equity spiked to 0.32 in Q3 2025, highest on record, before declining to 0.17 in Q1 2026.

⚠ Q3 2025 represented inflection point; all profitability metrics bottomed before sequential recovery through Q1 2026.

⚠ TTM ROIC of -65.1% remains severely negative; sustainability of Q4–Q1 gains unclear without operating profitability.

Get alerted when SVRA's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Savara Inc including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of SVRA

NEA Management Company, LLC
$133.6M24,471,264 sh
Bain Capital Life Sciences Investors, LLC
$96.1M17,600,621 sh
VR Adviser, LLC
$75.0M13,740,375 sh
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$74.1M13,569,000 sh
TCG Crossover Management, LLC
$67.5M12,362,205 sh
BlackRock, Inc.
$61.6M11,291,185 sh
Frazier Life Sciences Management, L.P.
$53.1M9,720,852 sh
Polar Capital Holdings Plc
$52.1M9,541,786 sh
VANGUARD CAPITAL MANAGEMENT LLC
$42.5M7,783,913 sh
Nantahala Capital Management, LLC
$40.1M7,344,783 sh

Fund	Value	Shares
NEA Management Company, LLC	$133.6M	24,471,264
Bain Capital Life Sciences Investors, LLC	$96.1M	17,600,621
VR Adviser, LLC	$75.0M	13,740,375
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	$74.1M	13,569,000
TCG Crossover Management, LLC	$67.5M	12,362,205
BlackRock, Inc.	$61.6M	11,291,185
Frazier Life Sciences Management, L.P.	$53.1M	9,720,852
Polar Capital Holdings Plc	$52.1M	9,541,786
VANGUARD CAPITAL MANAGEMENT LLC	$42.5M	7,783,913
Nantahala Capital Management, LLC	$40.1M	7,344,783

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put SVRA on your watchlist

Track score changes the day Savara Inc files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is SVRA a good stock to buy?

13F Pro's AI-powered analysis of Savara Inc (SVRA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SVRA are available on the SVRA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own SVRA?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SVRA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Savara Inc's investment landscape.